CEL-SCI plans U.S. study and Saudi deal for head and neck drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. RKLB
9. SPCX
10. NKE

Go back to CEL-SCI plans U.S. study and Saudi deal for head and neck drug
CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.11 +0.14 (14.43%)
Previous Close $0.97    52 Week High $0.66 
Open $1.00    52 Week Low $0.20 
Day High $1.11    P/E N/A 
Day Low $0.99    EPS $-0.34 
Volume 329,156